These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35535436)

  • 1. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
    Cinciripini PM; Kypriotakis G; Green C; Lawrence D; Anthenelli RM; Minnix J; Blalock JA; Beneventi D; Morris C; Karam-Hage M
    Depress Anxiety; 2022 May; 39(5):429-440. PubMed ID: 35535436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
    Heffner JL; Evins AE; Russ C; Lawrence D; Ayers CR; McRae T; Aubin LS; Krishen A; West R; Anthenelli RM
    J Affect Disord; 2019 Sep; 256():267-277. PubMed ID: 31195244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
    Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
    Anthenelli RM; Gaffney M; Benowitz NL; West R; McRae T; Russ C; Lawrence D; St Aubin L; Krishen A; Evins AE
    J Gen Intern Med; 2019 Jun; 34(6):862-870. PubMed ID: 30847828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
    JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
    Evins AE; Benowitz NL; West R; Russ C; McRae T; Lawrence D; Krishen A; St Aubin L; Maravic MC; Anthenelli RM
    J Clin Psychopharmacol; 2019; 39(2):108-116. PubMed ID: 30811371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors.
    Beard E; Jackson SE; Anthenelli RM; Benowitz NL; Aubin LS; McRae T; Lawrence D; Russ C; Krishen A; Evins AE; West R
    Addiction; 2021 Oct; 116(10):2816-2824. PubMed ID: 33885203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM
    JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial.
    Ayers CR; Heffner JL; Russ C; Lawrence D; McRae T; Evins AE; Anthenelli RM
    Depress Anxiety; 2020 Mar; 37(3):247-260. PubMed ID: 31850603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
    Davis JM; Masclans L; Rose JE
    JAMA Netw Open; 2023 Sep; 6(9):e2332214. PubMed ID: 37682573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES.
    Evins AE; West R; Benowitz NL; Russ C; Lawrence D; McRae T; Maravic MC; Heffner JL; Anthenelli RM
    Psychiatr Serv; 2021 Jan; 72(1):7-15. PubMed ID: 33138708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
    Ebbert J; Jimenez-Ruiz C; Dutro MP; Fisher M; Li J; Hays JT
    Mayo Clin Proc; 2021 Jul; 96(7):1801-1811. PubMed ID: 34112520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
    Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW
    JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
    Robles GI; Singh-Franco D; Ghin HL
    Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE; Behm FM
    Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.